HomeSWTX • NASDAQ
add
SpringWorks Therapeutics Inc
Previous close
$36.30
Day range
$36.24 - $39.61
Year range
$20.19 - $53.90
Market cap
2.90B USD
Avg Volume
1.23M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 49.30M | — |
Operating expense | 103.90M | 23.69% |
Net income | -53.53M | 32.61% |
Net profit margin | -108.58 | — |
Earnings per share | -0.72 | 43.31% |
EBITDA | -57.06M | 31.67% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 376.62M | -10.84% |
Total assets | 608.88M | 30.20% |
Total liabilities | 76.30M | 4.87% |
Total equity | 532.58M | — |
Shares outstanding | 74.37M | — |
Price to book | 5.06 | — |
Return on assets | -23.62% | — |
Return on capital | -26.26% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -53.53M | 32.61% |
Cash from operations | -25.38M | 49.71% |
Cash from investing | 28.65M | -17.20% |
Cash from financing | 1.29M | 633.47% |
Net change in cash | 4.56M | 128.32% |
Free cash flow | -6.42M | 76.45% |
About
Founded
2017
Headquarters
Website
Employees
305
